Most analysts on Wall Street were also very upbeat about the acquisition. HSP stock had previously climbed about 38% since last October, prior to the announcement. InvestorPlace’s Portfolio Grader identified HSP stock as a top pick just a few days ago.
Investor Place · 2/5/2015
Hospira Inc. ( HSP) was a big mover last session with its shares rising nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock
NASDAQ · 11/7/2014
Many investors look to Wall Street for guidance when it comes to which stocks they should be buying and selling ... Leo Sun: Hospira (NYSE: HSP ) is a hidden healthcare gem. Its business is split into specialty injectable pharmaceuticals, medication ...
The Motley Fool · 12/6/2014
More from Bing News
The increase in price target follows the news regarding the pharmaceutical company’s acquisition of Hospira, Inc. (NYSE:HSP). Mr. Baum holds a Buy rating on Pfizer stock. The bank said in the research note that it was increasing the earnings per share ... · 2/9/2015
The top two positions in the S&P 500 gainers were eliminated due to pending mergers. Hospira Inc. (NYSE: HSP) was the top performing S&P 500 stock with a 43.5% gain so far this year, but Pfizer Inc. (NYSE: PFE) is acquiring Hospira for $90 per share.
24/7 Wall ST · 3/30/2015
HSP) for more than $15 billion. In morning trading Thursday, the Dow Jones Industrial Average, which measures the share prices of 30 large industrial companies, jumped 159.01 points, or 0.90 percent, at 17,832.03; the S&P 500 stock index added 17.12 …
International Business Times · 2/5/2015
HSP is currently Zacks Rank # 5 (Strong Sell) stock and it also has a longer-term recommendation of “Underperform.” Further manufacturing issues at its Rocky Mountain facility (which did not comply with the regulatory standards according to FDA ...
Forbes · 4/2/2013
Pfizer (PFE) has pulled back into a buy range after jumping to new highs following its purchase of generic-drug maker Hospira (HSP) . Pfizer is still just ... a positive trait. Pfizer's stock is up 8% over the past year, trailing the S&P 500's 15% gain.
Investors Business Daily · ByScott Stoddard · 2/19/2015
Holford felt the pending acquisition of Hospira, Inc. (NYSE: HSP) was in line with the firm’s expectation ... Holford concluded that Pfizer was now the firm’s “most preferred stock within US Large Cap Pharma and globally for 2015,” and the analysts ...
Benzinga · 5/22/2015
Total consolidated revenues equaled $1.47 billion in fiscal 2014. HealthSpan Partners (HSP), a secular auxiliary organization of Mercy Health (fka Catholic Health Partners, rated 'AA-' by Fitch), purchased a 30% minority stake in Summa for $250 million in ...
Financial Content · 6/17/2015
EBITDA margin


Hospira, Inc. is a U.S.-based global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It has approximat…
Hospira, Inc. is a U.S.-based global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It has approximately 15,000 employees. Hospira is the world's largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories.
Data from: Wikipedia